{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:23:57Z","timestamp":1792034637417,"version":"4.4.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Rete Cardiologica from the Italian Ministry of Health"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry &amp; Cell Biology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.biocel.2020.105735","type":"journal-article","created":{"date-parts":[[2020,2,29]],"date-time":"2020-02-29T11:21:19Z","timestamp":1582975279000},"page":"105735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"special_numbering":"C","title":["Statins reduce vascular inflammation in atherogenesis: A review of underlying molecular mechanisms"],"prefix":"10.1016","volume":"122","author":[{"given":"Luca","family":"Liberale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0823-8729","authenticated-orcid":false,"given":"Fabrizio","family":"Montecucco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biocel.2020.105735_bib0005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.286.1.64","article-title":"Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation\/CRP evaluation (PRINCE): a randomized trial and cohort study","volume":"286","author":"Albert","year":"2001","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.biocel.2020.105735_bib0010","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJM199502233320802","article-title":"The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion","volume":"332","author":"Anderson","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"11 Suppl","key":"10.1016\/j.biocel.2020.105735_bib0015","first-page":"S66","article-title":"Preoperative atorvastatin treatment in CABG patients rapidly improves vein graft redox state by inhibition of Rac1 and NADPH-oxidase activity","volume":"122","author":"Antoniades","year":"2010","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.biocel.2020.105735_bib0020","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/CIRCULATIONAHA.110.985150","article-title":"Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling","volume":"124","author":"Antoniades","year":"2011","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.biocel.2020.105735_bib0025","doi-asserted-by":"crossref","first-page":"22212","DOI":"10.1074\/jbc.M502761200","article-title":"Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux","volume":"280","author":"Argmann","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biocel.2020.105735_bib0030","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6508709","article-title":"Simvastatin effects on inflammation and platelet activation markers in hypercholesterolemia","volume":"2018","author":"Barale","year":"2018","journal-title":"Biomed Res. Int."},{"issue":"1","key":"10.1016\/j.biocel.2020.105735_bib0035","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1160\/TH17-09-0630","article-title":"The pathophysiological role of neutrophil extracellular traps in inflammatory diseases","volume":"118","author":"Bonaventura","year":"2018","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.biocel.2020.105735_bib0040","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvz084","article-title":"Novel findings in neutrophil biology and their impact on cardiovascular disease","author":"Bonaventura","year":"2019","journal-title":"Cardiovasc. Res."},{"issue":"10","key":"10.1016\/j.biocel.2020.105735_bib0045","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1161\/hh2201.100319","article-title":"Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins","volume":"89","author":"Brouet","year":"2001","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.biocel.2020.105735_bib0050","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/S0735-1097(98)00487-2","article-title":"HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis","volume":"32","author":"Bustos","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"issue":"15","key":"10.1016\/j.biocel.2020.105735_bib0055","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"25","key":"10.1016\/j.biocel.2020.105735_bib0060","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"37","key":"10.1016\/j.biocel.2020.105735_bib0065","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.2174\/1381612822666160822124546","article-title":"Targeting inflammation in primary cardiovascular prevention","volume":"22","author":"Carbone","year":"2016","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.biocel.2020.105735_bib0070","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/01.CIR.0000022843.76104.01","article-title":"Simvastatin reduces neointimal thickening in low-density lipoprotein receptor-deficient mice after experimental angioplasty without changing plasma lipids","volume":"106","author":"Chen","year":"2002","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.biocel.2020.105735_bib0075","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000484648","article-title":"Atorvastatin calcium inhibits PDGF-betabeta-induced proliferation and migration of VSMCs through the G0\/G1 cell cycle arrest and suppression of activated PDGFRbeta-PI3K-Akt signaling cascade","volume":"44","author":"Chen","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.biocel.2020.105735_bib0080","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijcard.2008.10.044","article-title":"Modulation of human T cells signaling transduction by lovastatin","volume":"140","author":"Cheng","year":"2010","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.biocel.2020.105735_bib0085","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.atherosclerosis.2016.07.897","article-title":"Impact of statin therapy on plasma adiponectin concentrations: a systematic review and meta-analysis of 43 randomized controlled trial arms","volume":"253","author":"Chru\u015bciel","year":"2016","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.biocel.2020.105735_bib0090","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1161\/01.CIR.0000056530.03783.81","article-title":"Suppression of the functionally coupled cyclooxygenase-2\/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans","volume":"107","author":"Cipollone","year":"2003","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.biocel.2020.105735_bib0095","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/01.ATV.17.2.265","article-title":"Vastatins inhibit tissue factor in cultured human macrophages. A novel mechanism of protection against atherothrombosis","volume":"17","author":"Colli","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.biocel.2020.105735_bib0100","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/01.CIR.103.7.926","article-title":"Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization","volume":"103","author":"Crisby","year":"2001","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.biocel.2020.105735_bib0105","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.292.11.1307","article-title":"Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial","volume":"292","author":"de Lemos","year":"2004","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.biocel.2020.105735_bib0110","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1161\/01.ATV.0000043456.48735.20","article-title":"HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells","volume":"23","author":"Dichtl","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.biocel.2020.105735_bib0115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.tcm.2004.06.005","article-title":"An emerging role for Kruppel-like factors in vascular biology","volume":"14","author":"Feinberg","year":"2004","journal-title":"Trends Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.biocel.2020.105735_bib0120","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/01.CIR.103.1.113","article-title":"Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance","volume":"103","author":"Feron","year":"2001","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.biocel.2020.105735_bib0125","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1042\/BJ20070404","article-title":"Fluvastatin inhibits regulated secretion of endothelial cell von Willebrand factor in response to diverse secretagogues","volume":"405","author":"Fish","year":"2007","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.biocel.2020.105735_bib0130","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/01.RES.87.1.26","article-title":"A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall","volume":"87","author":"Gorlach","year":"2000","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.biocel.2020.105735_bib0135","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.it.2006.12.003","article-title":"Statins and the vascular endothelial inflammatory response","volume":"28","author":"Greenwood","year":"2007","journal-title":"Trends Immunol."},{"issue":"2","key":"10.1016\/j.biocel.2020.105735_bib0140","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/01.ATV.0000054659.72231.A1","article-title":"HMG-CoA reductase inhibitor increases GTP cyclohydrolase I mRNA and tetrahydrobiopterin in vascular endothelial cells","volume":"23","author":"Hattori","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.biocel.2020.105735_bib0145","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0008-6363(02)00619-3","article-title":"Simvastatin reduces NF-kappaB activity in peripheral mononuclear and in plaque cells of rabbit atheroma more markedly than lipid lowering diet","volume":"57","author":"Hernandez-Presa","year":"2003","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.biocel.2020.105735_bib0150","doi-asserted-by":"crossref","first-page":"H251","DOI":"10.1152\/ajpheart.00195.2009","article-title":"Regulation of the ADMA-DDAH system in endothelial cells: a novel mechanism for the sterol response element binding proteins, SREBP1c and -2","volume":"298","author":"Ivashchenko","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"5","key":"10.1016\/j.biocel.2020.105735_bib0155","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0735-1097(01)01128-7","article-title":"Rapid improvement of nitric oxide bioavailability after lipid-lowering therapy with cerivastatin within two weeks","volume":"37","author":"John","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.biocel.2020.105735_bib0160","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/01.ATV.0000018305.95943.F7","article-title":"Reversal of thrombin-induced deactivation of CD39\/ATPDase in endothelial cells by HMG-CoA reductase inhibition: effects on Rho-GTPase and adenosine nucleotide metabolism","volume":"22","author":"Kaneider","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.biocel.2020.105735_bib0165","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/00365519950185689","article-title":"Carvastatin suppresses intimal thickening of rabbit carotid artery after balloon catheter injury probably through the inhibition of vascular smooth muscle cell proliferation and migration","volume":"59","author":"Komukai","year":"1999","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"12","key":"10.1016\/j.biocel.2020.105735_bib0170","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/82219","article-title":"Statins as a newly recognized type of immunomodulator","volume":"6","author":"Kwak","year":"2000","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.biocel.2020.105735_bib0175","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S1568-9972(03)00049-1","article-title":"Atherosclerosis: anti-inflammatory and immunomodulatory activities of statins","volume":"2","author":"Kwak","year":"2003","journal-title":"Autoimmun. Rev."},{"issue":"12","key":"10.1016\/j.biocel.2020.105735_bib0180","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.CIR.97.12.1129","article-title":"Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors","volume":"97","author":"Laufs","year":"1998","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.biocel.2020.105735_bib0185","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1016\/j.jacc.2017.09.028","article-title":"Interleukin-1 beta as a target for atherosclerosis therapy: biological basis of CANTOS and beyond","volume":"70","author":"Libby","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.biocel.2020.105735_bib0190","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1160\/TH16-08-0593","article-title":"Pathophysiological relevance of macrophage subsets in atherogenesis","volume":"117","author":"Liberale","year":"2017","journal-title":"Thromb. Haemost."},{"issue":"47","key":"10.1016\/j.biocel.2020.105735_bib0195","doi-asserted-by":"crossref","first-page":"33334","DOI":"10.1074\/jbc.274.47.33334","article-title":"Integrin-dependent leukocyte adhesion involves geranylgeranylated protein(s)","volume":"274","author":"Liu","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.biocel.2020.105735_bib0200","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/00005344-200011000-00011","article-title":"Short-term atorvastatin treatment improves endothelial function in hypercholesterolemic women","volume":"36","author":"Marchesi","year":"2000","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.biocel.2020.105735_bib0205","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/cvr\/cvp375","article-title":"Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability","volume":"86","author":"Massaro","year":"2010","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.biocel.2020.105735_bib0210","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00005344-200403000-00002","article-title":"Simvastatin enhances the regeneration of endothelial cells via VEGF secretion in injured arteries","volume":"43","author":"Matsuno","year":"2004","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.biocel.2020.105735_bib0215","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0092-8674(03)00803-1","article-title":"Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor","volume":"115","author":"Matsushita","year":"2003","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.biocel.2020.105735_bib0220","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.atherosclerosis.2007.07.031","article-title":"The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells","volume":"197","author":"Mausner-Fainberg","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biocel.2020.105735_bib0225","doi-asserted-by":"crossref","first-page":"598","DOI":"10.2119\/molmed.2011.00471","article-title":"Statins induce the accumulation of regulatory T cells in atherosclerotic plaque","volume":"18","author":"Meng","year":"2012","journal-title":"Mol Med"},{"issue":"12","key":"10.1016\/j.biocel.2020.105735_bib0230","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1002\/1529-0131(200112)44:12<2870::AID-ART475>3.0.CO;2-Y","article-title":"Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype","volume":"44","author":"Meroni","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biocel.2020.105735_bib0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2018.04.006","article-title":"Innate and adaptive immunity in atherosclerosis","author":"Miteva","year":"2018","journal-title":"Vascul. Pharmacol."},{"issue":"3","key":"10.1016\/j.biocel.2020.105735_bib0240","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11883-017-0646-1","article-title":"The role of inflammation in cardiovascular outcome","volume":"19","author":"Montecucco","year":"2017","journal-title":"Curr. Atheroscler. Rep."},{"issue":"2","key":"10.1016\/j.biocel.2020.105735_bib0245","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/01.mbc.0000161563.36270.a2","article-title":"CD40-ligand-dependent induction of COX-2 gene expression in endothelial cells by activated platelets: inhibitory effects of atorvastatin","volume":"16","author":"Mosheimer","year":"2005","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"9","key":"10.1016\/j.biocel.2020.105735_bib0250","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1161\/ATVBAHA.109.190884","article-title":"Inhibition of platelet-rich arterial thrombus in vivo: acute antithrombotic effect of intravenous HMG-CoA reductase therapy","volume":"29","author":"Obi","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.biocel.2020.105735_bib0255","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","article-title":"Pleiotropic effects of statins on the cardiovascular system","volume":"120","author":"Oesterle","year":"2017","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.biocel.2020.105735_bib0260","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0021-9150(99)00193-8","article-title":"Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells","volume":"147","author":"Ortego","year":"1999","journal-title":"Atherosclerosis"},{"issue":"26","key":"10.1016\/j.biocel.2020.105735_bib0265","doi-asserted-by":"crossref","first-page":"14483","DOI":"10.1073\/pnas.94.26.14483","article-title":"Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II","volume":"94","author":"Pagano","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.biocel.2020.105735_bib0270","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11745-010-3517-x","article-title":"Simvastatin therapy reduces prooxidant-antioxidant balance: results of a placebo-controlled cross-over trial","volume":"46","author":"Parizadeh","year":"2011","journal-title":"Lipids"},{"issue":"5","key":"10.1016\/j.biocel.2020.105735_bib0275","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/ATVBAHA.109.184648","article-title":"Statin islands and PPAR ligands in platelets","volume":"29","author":"Phipps","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.biocel.2020.105735_bib0280","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8010118","article-title":"Effect of statin therapy on arterial wall inflammation based on 18F-FDG PET\/CT: a systematic review and meta-analysis of interventional studies","volume":"8","author":"Pirro","year":"2019","journal-title":"J. Clin. Med."},{"issue":"10","key":"10.1016\/j.biocel.2020.105735_bib0285","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.jacc.2003.08.017","article-title":"Peroxisome proliferator-activated receptors as therapeutic targets in inflammation","volume":"42","author":"Plutzky","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.biocel.2020.105735_bib0290","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2362.2005.01446.x","article-title":"Atorvastatin reduces platelet-oxidized-LDL receptor expression in hypercholesterolaemic patients","volume":"35","author":"Puccetti","year":"2005","journal-title":"Eur. J. Clin. Invest."},{"issue":"Pt 2","key":"10.1016\/j.biocel.2020.105735_bib0295","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1042\/bj3600363","article-title":"Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cells","volume":"360","author":"Rasmussen","year":"2001","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.biocel.2020.105735_bib0300","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1006\/bbrc.1995.1863","article-title":"Lovastatin inhibits proliferation and differentiation and causes apoptosis in lipopolysaccharide-stimulated murine B cells","volume":"211","author":"Reedquist","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"21","key":"10.1016\/j.biocel.2020.105735_bib0305","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biocel.2020.105735_bib0310","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0021-9150(00)00468-8","article-title":"Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits","volume":"154","author":"Rikitake","year":"2001","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.biocel.2020.105735_bib0315","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1161\/HYPERTENSIONAHA.107.091264","article-title":"HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA\/ROCK and MAPK pathways","volume":"50","author":"Ruperez","year":"2007","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.biocel.2020.105735_bib0320","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10557-013-6479-4","article-title":"New therapies targeting apoB metabolism for high-risk patients with inherited dyslipidaemias: what can the clinician expect?","volume":"27","author":"Sahebkar","year":"2013","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"2","key":"10.1016\/j.biocel.2020.105735_bib0325","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.atherosclerosis.2015.05.022","article-title":"Statin therapy reduces plasma endothelin-1 concentrations: a meta-analysis of 15 randomized controlled trials","volume":"241","author":"Sahebkar","year":"2015","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.biocel.2020.105735_bib0330","first-page":"546","article-title":"Association between statin use and plasma d-dimer levels: a systematic review and meta-analysis of randomised controlled trials","volume":"114","author":"Sahebkar","year":"2015","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.biocel.2020.105735_bib0335","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.104.525774","article-title":"Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells","volume":"112","author":"Sen-Banerjee","year":"2005","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.biocel.2020.105735_bib0340","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1172\/JCI7811","article-title":"Decreased neointimal formation in Mac-1(-\/-) mice reveals a role for inflammation in vascular repair after angioplasty","volume":"105","author":"Simon","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"21","key":"10.1016\/j.biocel.2020.105735_bib0345","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1053\/euhj.2002.3174","article-title":"Statin treatment is associated with reduced thermal heterogeneity in human atherosclerotic plaques","volume":"23","author":"Stefanadis","year":"2002","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.biocel.2020.105735_bib0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5551\/jat1994.5.1","article-title":"Geranylgeranylpyrophosphate plays a key role for the G1 to S transition in vascular smooth muscle cells","volume":"5","author":"Terano","year":"1998","journal-title":"J. Atheroscler. Thromb."},{"issue":"1","key":"10.1016\/j.biocel.2020.105735_bib0355","doi-asserted-by":"crossref","first-page":"H75","DOI":"10.1152\/ajpheart.2001.281.1.H75","article-title":"HMG-CoA reductase inhibitor stabilizes rabbit atheroma by increasing basal NO and decreasing superoxide","volume":"281","author":"Thakur","year":"2001","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"8","key":"10.1016\/j.biocel.2020.105735_bib0360","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM199502233320801","article-title":"Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease","volume":"332","author":"Treasure","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.biocel.2020.105735_bib0365","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/hc2901.094094","article-title":"Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days","volume":"104","author":"Tsunekawa","year":"2001","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.biocel.2020.105735_bib0370","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1096\/fj.04-2852fje","article-title":"Simvastatin inhibits MMP-9 secretion from human saphenous vein smooth muscle cells by inhibiting the RhoA\/ROCK pathway and reducing MMP-9 mRNA levels","volume":"19","author":"Turner","year":"2005","journal-title":"FASEB J."},{"issue":"18","key":"10.1016\/j.biocel.2020.105735_bib0375","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1101\/gad.11.18.2295","article-title":"Rho GTPases and signaling networks","volume":"11","author":"Van Aelst","year":"1997","journal-title":"Genes Dev."},{"issue":"1","key":"10.1016\/j.biocel.2020.105735_bib0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053882","article-title":"A clinical evaluation of statin pleiotropy: statins selectively and dose-dependently reduce vascular inflammation","volume":"8","author":"van der Meij","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.biocel.2020.105735_bib0385","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1089\/ars.2013.5527","article-title":"Statins as regulators of redox signaling in platelets","volume":"20","author":"Violi","year":"2014","journal-title":"Antioxid. Redox Signal."},{"issue":"11","key":"10.1016\/j.biocel.2020.105735_bib0390","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1161\/01.ATV.0000037098.20829.31","article-title":"3-hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells","volume":"22","author":"Wagner","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.biocel.2020.105735_bib0395","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molmed.2007.11.004","article-title":"Pleiotropic effects of statin therapy: molecular mechanisms and clinical results","volume":"14","author":"Wang","year":"2008","journal-title":"Trends Mol. Med."},{"issue":"2","key":"10.1016\/j.biocel.2020.105735_bib0400","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1161\/hq0202.104081","article-title":"Cellular antioxidant effects of atorvastatin in vitro and in vivo","volume":"22","author":"Wassmann","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.biocel.2020.105735_bib0405","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/01.HYP.0000142232.29764.a7","article-title":"Modulation of oxidant and antioxidant enzyme expression and function in vascular cells","volume":"44","author":"Wassmann","year":"2004","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.biocel.2020.105735_bib0410","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/S0735-1097(97)00324-0","article-title":"HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia","volume":"30","author":"Weber","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.biocel.2020.105735_bib0415","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/89058","article-title":"Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site","volume":"7","author":"Weitz-Schmidt","year":"2001","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.biocel.2020.105735_bib0420","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/HCO.0000000000000518","article-title":"An update on trials of novel lipid-lowering drugs","volume":"33","author":"Wierzbicki","year":"2018","journal-title":"Curr. Opin. Cardiol."},{"issue":"7","key":"10.1016\/j.biocel.2020.105735_bib0425","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1161\/hq0701.092143","article-title":"Hmg-CoA reductase inhibitor modulates monocyte-endothelial cell interaction under physiological flow conditions in vitro: involvement of Rho GTPase-dependent mechanism","volume":"21","author":"Yoshida","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["The International Journal of Biochemistry &amp; Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272520300522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272520300522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T07:16:42Z","timestamp":1761203802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272520300522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":85,"alternative-id":["S1357272520300522"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2020.105735","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statins reduce vascular inflammation in atherogenesis: A review of underlying molecular mechanisms","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2020.105735","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105735"}}